Philippe Delataille

444 total citations
5 papers, 388 citations indexed

About

Philippe Delataille is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Philippe Delataille has authored 5 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cardiology and Cardiovascular Medicine, 3 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Philippe Delataille's work include Liver Disease Diagnosis and Treatment (3 papers), Biochemical effects in animals (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Philippe Delataille is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Biochemical effects in animals (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Philippe Delataille collaborates with scholars based in France. Philippe Delataille's co-authors include Bart Staels, Dean W. Hum, Bertrand Cariou, Rémy Hanf, Lesley J. Millatt, Benoît Noël, Anne Tailleux, Vlad Ratziu, Morgane Baron and A. Rubenstrunk and has published in prestigious journals such as Hepatology, Journal of Hepatology and Diabetes and Vascular Disease Research.

In The Last Decade

Philippe Delataille

5 papers receiving 377 citations

Peers

Philippe Delataille

EPIDE

MB

EDM

HEPAT

SURGE

Masafumi Uno Japan

Jacqueline Williams Australia

Rizwana Mohseni United States

F. Mirshahi United States

Francesca Virginia Bruschi Austria

Ramchandra Ranvir India

Akshyaya Rath India

Eliza Harting United States

Pengbo Wu China

Liang‐Jie Tang China

Masafumi Uno Japan

Philippe Delataille

288 ×0.9

EPIDE

146 ×0.9

MB

147 ×1.1

EDM

81 ×0.7

HEPAT

77 ×1.3

SURGE

Citations per year, relative to Philippe Delataille Philippe Delataille (= 1×) peers Masafumi Uno

Countries citing papers authored by Philippe Delataille

Since Specialization

Citations

This map shows the geographic impact of Philippe Delataille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Delataille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Delataille more than expected).

Fields of papers citing papers by Philippe Delataille

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Delataille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Delataille. The network helps show where Philippe Delataille may publish in the future.

Co-authorship network of co-authors of Philippe Delataille

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Delataille. A scholar is included among the top collaborators of Philippe Delataille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Delataille. Philippe Delataille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Bobowski, Marie, Philippe Delataille, Rémy Hanf, et al.. (2024). WED-105 Nitazoxanide directly protects from stress-induced cell death to alleviate liver damage in preclinical models of acute-on-chronic liver failure. Journal of Hepatology. 80. S191–S191. 1 indexed citations

2.

Legry, Vanessa, et al.. (2022). Improvement of hepatic and extrahepatic functions and anti-inflammatory effects of nitazoxanide in disease models of LPS-induced systemic inflammation and acute-on-chronic liver failure. Journal of Hepatology. 77. S359–S360. 1 indexed citations

3.

Majd, Zouher, et al.. (2016). RORgt Inhibition in the Liver Prevents Hepatic Fibrosis Progression, a Proof of Concept Study with a Potent, First in Class, Hepatocentric RORgt Inverse Agonist. Journal of Hepatology. 64(2). S523–S523. 2 indexed citations

4.

Hanf, Rémy, Lesley J. Millatt, Bertrand Cariou, et al.. (2014). The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma–associated adverse cardiac effects. Diabetes and Vascular Disease Research. 11(6). 440–447. 34 indexed citations

5.

Staels, Bart, A. Rubenstrunk, Benoît Noël, et al.. (2013). Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology. 58(6). 1941–1952. 350 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact